J Lamarche - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J Lamarche

Showing results (91-100 of 95) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 95 results.

Journal of Medicinal Chemistry|June 28, 2016

Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase InhibitorJorge Garcia Fortanet, Christine Hiu-Tung Chen, Ying-Nan P Chen, et al.

Journal of Medicinal Chemistry|September 16, 2005

Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonistsPhilip R Kym, Rajesh Iyengar, Andrew J Souers, et al.

Scientific Reports|January 15, 2021

SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanismsYe Wang, Morvarid Mohseni, Angelo Grauel, et al.

Nature|July 1, 2016

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P Chen, Matthew J LaMarche, Ho Man Chan, et al.

Journal of Medicinal Chemistry|September 10, 2020

Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.

Pageof 10

Search research articles

Showing results (91-100 of 95) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 95 results.

Journal of Medicinal Chemistry|June 28, 2016

Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase InhibitorJorge Garcia Fortanet, Christine Hiu-Tung Chen, Ying-Nan P Chen, et al.

Journal of Medicinal Chemistry|September 16, 2005

Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonistsPhilip R Kym, Rajesh Iyengar, Andrew J Souers, et al.

Scientific Reports|January 15, 2021

SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanismsYe Wang, Morvarid Mohseni, Angelo Grauel, et al.

Nature|July 1, 2016

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P Chen, Matthew J LaMarche, Ho Man Chan, et al.

Journal of Medicinal Chemistry|September 10, 2020

Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.

Pageof 10